- Previous allergic reaction or anaphylaxis

- Pregnancy or if planning to become pregnant (relative contraindication - should be used for cancer treatment during pregnancy when indicated as a first-line agent)

- Current active viral or bacterial infections

- Severe hepatic impairment and/or total serum bilirubin over 5.0 mg/dL

- Myocardial infarction within the last 30 days before treatment

- Prior treatment to a maximum dose of 550 mg/m^2 with doxorubicin or other anthracycline agents

- Systolic dysfunction/cardiomyopathy not optimized on medical therapy

- Intramuscular or subcutaneous administration